News for Investigators

The BRC is reviving its Patient and Public Involvement (PPI) bursary fund.

The development of autonomic dysfunction is associated with a more rapid development of disease milestones and shorter survival in patients with Parkinson’s disease (PD), according to research published in JAMA Neurology.

Our BRC’S Mental Health theme has invested over £1 million in eight awards for early career researchers.  The projects reflect a range of issues within the area of mental health including: diagnostic categories and classification, drug repurposing, subjective awareness, risk factors for disease,

Researchers have demonstrated the genetic and clinical characteristics of a rare form of Charcot Marie Tooth Disease (CMT), an incurable genetic disease of the nerves that causes progressive and debilitating muscle weakness and sensory loss.

The development of a novel tool promises to greatly enhance researchers’ understanding of epileptic seizures.

Registration is open to apply to attend a three day workshop on frugal medical technology innovation hosted by the UCL Institute of Healthcare Engineering.

Investigators, patients and the public are invited to a special event to hear updates from the Targit trials team, who look at radiotherapy methods for breast cancer.

A landmark study is exploring potential biomarkers for Alzheimer’s disease and other dementias using participants that have been followed since 1946.

A University College Hospital patient was diagnosed with prostate cancer using a hyperpolarised MRI scan in August 2017, as part of a UCL trial looking to develop more accurate and personalised treatment for cancer.

Registration is now open to attend the UCL Infection, Immunology and Inflammation symposium.

The NIHR 11th annual Senior Investigator competition has opened.

Investigators are encouraged to engage with Apollo Therapeutics if their research is considered at the right stage for a translational approach.

We are looking for UCLH/UCL researchers to help us get students excited about clinical research by talking about their research careers as part of our research open day on 4 July.

A collaboration between UCL’s Translational Imaging Group (TIG) and Innersight Labs has won funding from MedCity’s ‘Collaborate to Innovate’ programme, a £2m initiative to commercialise life sciences discoveries through academic partnerships.

Researchers have demonstrated the genetic basis of a group of rare, progressive, metabolic diseases that affect the brain, spinal cord and often the peripheral nerves called leukodystrophies.